Annual Report

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

Flexible Solutions posts modest 2025 revenue gains, but a major strategic shift to food-grade products and new factories sets the stage for a breakout year.

As LandBridge prepares for its March Investor Day, all eyes are on its strategy to leverage Permian Basin acreage for both energy and digital growth.

As Cellebrite prepares to report its 2025 results, all eyes are on its performance as a key indicator for the future of AI in law enforcement and public safety.

A new PwC survey shows CEO optimism plummeting as most firms fail to monetize AI, while a select few reap huge rewards, widening a dangerous gap.

As Sherritt prepares its 2025 results, investors watch how it navigated volatile nickel and cobalt markets while its Cuban energy unit thrived.

The Bank of Greenland raises its 2025 profit outlook, signaling resilience as the nation navigates a tourism boom and challenges in its fishing industry.

Hillman Solutions sets its Q4 2025 earnings date, putting its unique operational strategy and the broader hardware retail market under the microscope.

As Fortis prepares its 2025 financial report, investors eye its massive capital plan and strategy for navigating the energy transition and surging demand.

A decade ago, a startup aimed to change the food system. Today, Green Boy Group is a global powerhouse fueling the plant-based food reformation.

After a major Q3 loss from a strategic loan sale, all eyes are on First Internet Bancorp's full-year results to see if its digital pivot is paying off.

IDEXX prepares to release its 2025 results, with all eyes on whether its high-tech product launches can sustain momentum in a complex pet care market.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

European FinTech Multitude AG unveils its 2026 financial calendar, offering investors a clear roadmap amid strong growth and evolving market dynamics.

Facing an OSC probe and audit delays, the legal tech firm is now seeking court relief, raising red flags for investors about its governance and finances.